Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene Using CRISPR/Cas9 Genome Editing

被引:0
|
作者
Khomyakova, E. A. [1 ]
Fedorenko, A. V. [1 ,5 ]
Surdina, A. V. [1 ]
Volovikov, E. A. [1 ,2 ]
Belikova, L. D. [1 ,2 ]
Zerkalenkova, E. A. [3 ]
Lagarkova, M. A. [1 ,4 ]
Bogomazova, A. N. [1 ,2 ,4 ]
机构
[1] Fed Med Biol Agcy, Lopukhin Fed Res & Clin Ctr Phys Chem Med, Moscow 119435, Russia
[2] Russian Acad Sci, Tomsk Natl Res Med Ctr, Res Inst Med Genet, Tomsk 634050, Russia
[3] Rogachev Fed Sci & Clin Ctr Pediat Hematol Oncol &, Moscow, Russia
[4] Lopukhin Fed Res & Clin Ctr Phys & Chem Med, Ctr Precis Genome Editing & Genet Technol Biomed, Fed Res & Clin Ctr Phys Chem Med, Moscow 119435, Russia
[5] Skolkovo Inst Sci & Technol, Moscow 121205, Russia
基金
俄罗斯科学基金会;
关键词
Nascimento type X-linked mental retardation; induced pluripotent stem cells; UBE2A gene; gene knockout; HISTONE H2B; ENZYME;
D O I
10.1134/S1062360423060048
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The deletions and mutations in the UBE2A gene cause X-linked mental retardation syndrome of the Nascimento type first described in 2006 (Nascimento et al., 2006). At the moment, approximately two dozen missense and nonsense mutations in the UBE2A gene associated with Nascimento-type mental retardation syndrome are known (Cordeddu et al., 2020). To study the role of the UBE2A gene in neurodevelopment, the authors generated a human iPSC line with knockout of the UBE2A gene (RCPCMi009-A-1) using genome editing CRISPR/Cas9 technology. The knockout of the UBE2A gene was confirmed by Western blotting. The pluripotent state of the RCPCMi009-A-1 iPSC line was confirmed by typical stem cell morphology, normal male karyotype (46,XY) maintenance, expression of pluripotency markers, and the ability to differentiate into the derivatives of three germ layers.
引用
收藏
页码:365 / 373
页数:9
相关论文
共 50 条
  • [1] Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene Using CRISPR/Cas9 Genome Editing
    E. A. Khomyakova
    A. V. Fedorenko
    A. V. Surdina
    E. A. Volovikov
    L. D. Belikova
    E. A. Zerkalenkova
    M. A. Lagarkova
    A. N. Bogomazova
    Russian Journal of Developmental Biology, 2023, 54 : 365 - 373
  • [2] Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing
    Bogomiakova, M. E.
    Sekretova, E. K.
    Eremeev, A. V.
    Shuvalova, L. D.
    Bobrovsky, P. A.
    Zerkalenkova, E. A.
    Lebedeva, O. S.
    Lagarkova, M. A.
    STEM CELL RESEARCH, 2021, 55
  • [3] Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
    Ben Jehuda, Ronen
    Shemer, Yuval
    Binah, Ofer
    STEM CELL REVIEWS AND REPORTS, 2018, 14 (03) : 323 - 336
  • [4] Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
    Ronen Ben Jehuda
    Yuval Shemer
    Ofer Binah
    Stem Cell Reviews and Reports, 2018, 14 : 323 - 336
  • [5] Derivation and characterization of induced pluripotent stem cells lines with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing
    Bogomiakova, M. E.
    Bobrovsky, P. A.
    Zhukova, Y. N.
    Lazarev, V. N.
    Lagarkova, M. A.
    FEBS OPEN BIO, 2018, 8 : 152 - 153
  • [6] Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9
    Yumlu, Saniye
    Stumm, Juergen
    Bashir, Sanum
    Dreyer, Anne-Kathrin
    Lisowski, Pawel
    Danner, Eric
    Kuehn, Ralf
    METHODS, 2017, 121 : 29 - 44
  • [7] Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing
    Gulimiheranmu, Maisumu
    Li, Shuang
    Zhou, Junmei
    STEM CELL RESEARCH, 2022, 62
  • [8] Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing
    Yi, Tong
    Bai, Rui
    Sun, Hairui
    Lan, Feng
    Zhang, Hongjia
    He, Yihua
    STEM CELL RESEARCH, 2020, 47
  • [9] Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Maierhof, Smilla K.
    Schinke, Christian
    Cernoch, Janine
    Hew, Lois
    Bruske, Laura Pauline
    Vallone, Valeria Fernandez
    Fischer, Kristin
    Stachelscheid, Harald
    Huehnchen, Petra
    Endres, Matthias
    Diecke, Sebastian
    Telugu, Narasimha Swamy
    Boehmerle, Wolfgang
    STEM CELL RESEARCH, 2023, 73
  • [10] CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells
    Zhang, Yanli
    Sastre, Danuta
    Wang, Feng
    CURRENT STEM CELL RESEARCH & THERAPY, 2018, 13 (04) : 243 - 251